|
Nycomed to acquire local portfolio from Sanofi-Aventis and Zentiva
|
03 August 2009 |
|
Nycomed announces FDA filing for Daxas® in COPD
|
21 July 2009 |
|
Nycomed receives Marketing Authorization for Pantoprazole 20mg OTC from European Commission
|
20 June 2009 |
|
Nycomed Reports a Solid Start to 2009
|
28 May 2009 |
|
Nycomed files European marketing authorisation application for Daxas®
|
11 May 2009 |
|
Nycomed reports a satisfactory 2008
|
24 February 2009 |
|
Nycomed strengthens its osteoporosis portfolio
|
15 January 2009 |
|
Nycomed optimises its European manufacturing network
|
24 September 2008 |
|
Nycomed - strong results in second quarter 2008
|
19 August 2008 |
|
Nycomed's preclinical anti-cancer program sold to Bayer Schering Pharma
|
08 August 2008 |
|
Nycomed sells oncology programs to 4SC
|
05 June 2008 |
|
A promising start into 2008 for Nycomed
|
21 May 2008 |
|
Nycomed intends to move chemical production to Indian joint venture
|
11 March 2008 |
|
A successful 2007 paves the way for future of Nycomed
|
10 March 2008 |
|
Nycomed creates a leading specialty pharmaceutical player in dermatology
|
23 February 2008 |
|
Nycomed and Wyeth announce launch of an own generic version of PROTONIX®
|
30 January 2008 |
|
Nycomed significantly increases profitability
|
20 November 2007 |
|
Nycomed signs definitive agreement to acquire Bradley Pharmaceuticals, Inc.
|
30 October 2007 |
|
Nycomed and NPS Pharmaceuticals Announce Licensing Agreement for GATTEX™
|
27 September 2007 |